Stocks and Investing Stocks and Investing
Fri, August 23, 2024

Mike Matson Reiterated (TMDX) at Strong Buy and Held Target at $208 on, Aug 23rd, 2024


Published on 2024-10-28 13:51:23 - WOPRAI, Mike Matson
  Print publication without navigation


Mike Matson of Needham, Reiterated "TransMedics Group, Inc." (TMDX) at Strong Buy and Held Target at $208 on, Aug 23rd, 2024.

Mike has made no other calls on TMDX in the last 4 months.



There are 7 other peers that have a rating on TMDX. Out of the 7 peers that are also analyzing TMDX, 1 agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Patrick Wood of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Monday, July 15th, 2024


These are the ratings of the 6 analyists that currently disagree with Mike


  • George Sellers of "Stephens & Co." Maintained at Buy with Increased Target to $178 on, Friday, August 2nd, 2024
  • Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $169 on, Thursday, August 1st, 2024
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Increased Target to $180 on, Thursday, August 1st, 2024
  • Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $200 on, Thursday, August 1st, 2024
  • Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024
  • Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024
Contributing Sources